Sublingual versus oral misoprostol for uterine evacuation following early pregnancy failure

International Journal of Gynecology and Obstetrics

Volumn 106, Issue 1, 2009, Pages 43-45

  Kushwah, Beenu ^a   Singh, Abha ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Early pregnancy failure; Medical termination of pregnancy; Misoprostol; Oral route; Sublingual route

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FEVER; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PREGNANCY DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; UTERUS; VOMITING;

EID: 67349170605     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.02.016     Document Type: Article

References (25)

1. Child T.J., Thomas J., Rees M., and Mac Kenzie. A comparative study of surgical and medical procedures: 932 pregnancy termination up to 63 days gestation. Hum Reprod 16 1 (2001) 67-71
2. Graziosi G.M., Mol B.W., Ankun W.M., and Bruinse H.W. Management of early pregnancy loss. Int J Gynecol Obstet 86 3 (2004) 337-346
3. Thong K.J., and Baird D.T. Induction of abortion with mifepristone and misoprostol in early pregnancy. BJOG 99 12 (1992) 1004-1007
4. Peyron R., Aubemy E., Tagosz V., Silvertre L., Renault M., Eikik F., et al. Early termination of pregnancy with mifepristone (RU 486) and the only active prostaglandin misoprostol. N Engl J Med 328 21 (1993) 1509-1513
5. El-Refaey H., Rajasekar D., Abdalla M., Calder L., and Templeton A. Induction of abortion with Mifepristone (RU 486) and oral or vaginal Misoprostol. N Engl J Med 332 15 (1995) 983-987
6. Ashok P.W., Flett G.W., and Templeton A. Termination of pregnancy at 9-13 weeks amenorrhea with Mifepristone and Misoprstol. Lancet 352 9127 (1998) 542-543
7. World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of Mifepristone. BMJ 307 6903 (1993) 532-537
8. VonHurtzen H. Research on regimen for early abortion. J Am Med Womens Assoc 55 3 Suppl (2000) 133-136
9. World Health Organization. Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost: a randomized controlled trial. Acta Obstet Gynecol Scand 80 5 (2001) 447-451
10. Ho P.C., Ngai S.W., Liu K.L., Wong G.C., and Lee S.W. Vaginal misopristol compared with oral misopristol in termination of second trimester pregnancy. Obstet Gynecol 90 5 (1997) 735-738
11. Zieman M., Fong S.K., Benovitz N.L., Banskter D., and Darney P.D. Abortion kinetics of misopristol with oral or vaginal administration. Obstet Gynecol 90 (1997) 88-92
12. Carbonell J.L., Varela L., Velazeo A., and Fernandez C. The use of misopristol for termination of early pregnancy. Contraception 55 3 (1997) 165-168
13. Carbonell J.L.L., Varela L., Tanda R., Cabezas E., and Sanctez C. Early abortion with 800 μg of misopristol by vaginal route. Contraception 59 4 (1999) 219-225
14. Tang O.S., Soohweer H., Seyberth H.W., Lee S.W., and Ho P.G. Pharmacokinetics of different routes of administration of misopristol. Hum Reprod 17 2 (2002) 332-336
15. Aronsson A., Gemzell Damelsson K., and Bygdeman M. Effects of misoprostol on uterine contractility following different routes of administration. Hum Reprod 19 1 (2004) 81-88
16. Meckstroth K.R., Whitaker A.K., Bertisch S., Goldberg A.B., and Danney P.D. Misoprostol administered by epithelial routes: drug absorption and uterine response. Obstet Gynecol 108 3 Pt 1 (2006) 582-590
17. Tang O.S., Miao B.Y., Lee S.W., and Chung H.o. Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: efficacy and acceptability. Hum Reprod 17 3 (2002) 654-658
18. Alberman E., Grudzinskas G., and Chardt G. Spontaneous Abortion: Diagnosis and treatment (1992), Springer Verlag, London, England 9-20
19. El-Refaey H., Hinshaw K., Hinshaw R., Smith N., and Templeton A. Medical management of missed abortion and anembryonic pregnancy. BMJ 305 6866 (1992) 1399
20. Mitchell D.C., Robert M., and Richard G. Misoprostol for medical evacuation of early pregnancy failure. Obstet Gynecol Surv 89 5 Pt 1 (1997) 768-772
21. Ngai S.W., Chan Y.M., Tang O.S., and Ho P.C. Vaginal misoprostol as medical treatment of first trimester miscarriage. Hum Reprod 16 (2001) 1493-1496
22. Waggarachchi P.T., Ashok P.W., Smith N., and Templeton A. Medical management of early fetal demise using sublingual Misoprostol. BJOG 109 4 (2002) 462-465
23. Tang O.S., Ting Lari W., Yu Ng E., Lee S., and Chung Ho P. A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriages. Hum Reprod 18 1 (2003) 176-181
24. Spitz I.M., and Bardin C.W. Clinical pharmacology of RU486: an antiprogestin and antiglucocorticoid. Contraception 48 5 (1993) 403-444
25. Cheung W., Tang O.S., Lee S.W., and Ho P.C. Pilot study on the use of sublingual misoprostol in termination of pregnancy up to 7 weeks gestation. Contraception 68 2 (2003) 97-99